Virtus ETF Advisers LLC Bicycle Therapeutics PLC Transaction History
Virtus ETF Advisers LLC
- $234 Million
- Q4 2024
A detailed history of Virtus ETF Advisers LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 3,535 shares of BCYC stock, worth $36,693. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,535
Previous 3,789
6.7%
Holding current value
$36,693
Previous $85,000
42.35%
% of portfolio
0.02%
Previous 0.04%
Shares
15 transactions
Others Institutions Holding BCYC
# of Institutions
104Shares Held
42.9MCall Options Held
12.1KPut Options Held
17.4K-
Baker Bros. Advisors LP New York, NY10.9MShares$113 Million1.69% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.55MShares$47.3 Million0.15% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$35.8 Million8.16% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.61MShares$27.1 Million0.17% of portfolio
-
Armistice Capital, LLC New York, NY2.2MShares$22.8 Million0.43% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $308M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...